New Company Launches to Help Institutional Investors Navigate Life Contingent Market

JERSEY CITY, N.J., March 29, 2012 /PRNewswire/ -- Former members of Chartis Risk Solutions recently launched Miravast, a risk management firm specializing in life contingent assets.  Emerging life contingent investments, such as life settlements (also known as the secondary market for life insurance), can deliver an attractive risk-adjusted return with low volatility as they are largely uncorrelated to traditional markets. Miravast will have an initial emphasis on the life settlement market; however, Miravast expects to quickly expand opportunities for its clients through applying its expertise to a full array of life contingent products.

Led by Bill Taylor, the former Senior Vice President and Chief Underwriting Officer of the Chartis Global Risk Solutions division, the Miravast management team brings experience, knowledge and a successful track record of investing in life contingent assets to institutional investors.  Miravast offers a full range of services including customized investment opportunities, asset management and specialized consulting services, all of which include the competitive advantage of the work performed by the Miravast medical underwriting team. 

"There is a void in this market that we are looking to fill," said Taylor. "Currently, investors are unsure of how to invest or who to trust.  We have more than a decade of experience investing in this asset class as well as working with outstanding service providers. Miravast is meant to bridge the gap for investors and provide turnkey access to investing in life contingent assets."

Taylor was the founder of the life settlement investment platform at Chartis Global Risk Solutions. Including Taylor, the current Miravast team consists of ten former members of the Chartis Global Risk Solutions team. The team was responsible for the development of a center of excellence in elderly mortality, the development of various life contingent products and the ongoing underwriting, acquisition and management of the largest life settlement portfolio with a total face value of more than $20 billion.

In addition to Taylor, Kenneth Zinn, joins Miravast as Vice President and Medical Director. Zinn, who has more than 32 years of medical underwriting experience, developed and managed the Medical Underwriting department within the Chartis Global Risk Solutions division. Under his leadership, his team of medical underwriters produced more than 100,000 medical underwriting assessments between 2001 and 2011.

ABOUT MIRAVAST

Miravast is a risk management firm specializing in life contingent assets.  Miravast is uniquely positioned to provide institutional investors with the tools to access this asset class. It has the only management team with the experience of investing over $5.0 billion in life settlements, along with providing over 100,000 medical underwriting assessments.     

Media Contact:
Emilie Lehan
[email protected]
(212) 279-3115 ext. 244

SOURCE Miravast